Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

ClinicalTrials.gov ID: NCT04617275

Public ClinicalTrials.gov record NCT04617275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF PF-06882961 TITRATION IN ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH METFORMIN AND IN NON-DIABETIC ADULTS WITH OBESITY

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess tolerability, safety, and pharmacodynamics (PD) of twice daily (BID) administration of PF- 06882961 in adult participants with Type 2 Diabetes Mellitus (T2DM) who are treated with metformin and in non-diabetic adults with obesity

Study identification

NCT ID
NCT04617275
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2021 (Actual)
Primary completion
Nov 17, 2021 (Actual)
Completion
Nov 17, 2021 (Actual)
Last update posted
Dec 8, 2022

2021

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
34
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053 —
Unity Health - Searcy Medical Center Searcy Arkansas 72143 —
Catalina Research Institute, LLC Montclair California 91763 —
Desert Oasis Healthcare Medical Group Palm Springs California 92262 —
Rancho Cucamonga Clinical Research Rancho Cucamonga California 91730 —
California Research Foundation San Diego California 92123-1881 —
University Clinical Investigators, Inc. Tustin California 92780 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Emerson Clinical Research Institute Washington D.C. District of Columbia 20011 —
Innovative Research of West Florida, Inc. Clearwater Florida 33756 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
Acevedo Clinical Research Associates Miami Florida 33142 —
Pines Care Research Center, LLC Pembroke Pines Florida 33024 —
Solaris Clinical Research Meridian Idaho 83646 —
Meridian Clinical Research, LLC Sioux City Iowa 51106 —
Research Integrity, LLC Owensboro Kentucky 42303 —
Nola Care LLC Metairie Louisiana 70006 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Meridian Clinical Research, LLC DBA Regional Clinical Research Endwell New York 13760 —
PMG Research of Raleigh, LLC d/b/a PMG Research of Cary Cary North Carolina 27518 —
PMG Research of Charlotte, LLC Charlotte North Carolina 28209 —
PMG Research of Hickory, LLC Hickory North Carolina 28601 —
PMG Research of Rocky Mount, LLC - Investigational Product and Mail delivery Rocky Mount North Carolina 27804 —
PMG Research of Rocky Mount, LLC - Patient Visits Rocky Mount North Carolina 27804 —
Carolina Research Center, Inc. Shelby North Carolina 28150 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
Sterling Research Group, Ltd. Cincinnati Ohio 45219 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Palmetto Clinical Research Summerville South Carolina 29485 —
Palmetto Primary Care Physicians (physicals only) Summerville South Carolina 29485 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Juno Research, LLC Houston Texas 77074 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Bountiful Internal Medicine Bountiful Utah 84010 —
Progressive Clinical Research Bountiful Utah 84010 —
Wade Family Medicine Bountiful Utah 84010 —
Manassas Clinical Research Center Manassas Virginia 20110 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04617275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04617275 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →